SENSEX NIFTY
Strides Arcolab > Company History > Pharmaceuticals > Company History of Strides Arcolab - BSE: 532531, NSE: STAR
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > COMPANY BACKGROUND - Strides Arcolab
Strides Arcolab
BSE: 532531|NSE: STAR|ISIN: INE939A01011|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 27, 16:00
786.25
51.35 (6.99%)
VOLUME 216,386
LIVE
NSE
Nov 27, 15:57
786.65
50.3 (6.83%)
VOLUME 968,700
Company History - Strides Arcolab
2002
 
 -Board approves for the allotment of 210,955 shares of the company at
 Rs.10 each to the share holders of Bombay Drugs & Pharmas Ltd.
 
 -Zenith Pharmaceuticals Ltd acquires 71% shares through preferential
 issue route.
 
 -Board approves for the proposal of restructuring its Cram division
 by hiving off into two separate company under the provisions of the
 companies act.
 
 -Incorporates 'Strides Africa Ltd' at British Virgin Island with an
 authorised capital of US $ 200,000 as 100% wholly owned subsidiary.
 
 -Board decides to change the name of the company to 'Strides Arcolab
 (FA)' to reflect the change in the business focus and operations.
 
 2003
 
 -Nominates Mr Francis Pinto as the Director on the Board of the
 company.
 
 -Forges an exclusive co-operation alliance with the South Africa
 based drug manufacturer Aspen Pharmacare, mainly to share the product
 development expertise and quality systems.
 
 -Concludes the strategic development and manufacturing agreement with
 Sorm Co. Ltd  for long term supply of Generics, OTC and Nutraceutical
 products.
 
 -Changes in the Management:
 Appoints Mr V Hariharan as CFO, Mr Joe Thomas as President, and Mr
 Krishna Kumar Menon as COO.
 
 -Board approves for the reorganization of subsidiaries of the company
 and for write off of dimunition in value of investments made in
 subsidiaries by the company.
 
 -Strides inks MoU with Ribbon SRL for Cephalosporin
 
 2004
 
 -Major Fire occurs in Private Custom Bonded warehouse in Mexico
 
 -Strides Arcolab Limited has entered into a memorandum of
 understanding with BITS, Pilani for an ``off campus collaborative
 programme''. As part of the partnership, Strides has launched a new
 initiative called STEP (Strides Training and Education Plan) intend
 to offer their employees an opportunity to acquire a MS in Pharma
 Operations & Management while on the job.
 
 2005
 
 - Enters into an agreement with Mayne Pharma Business Unit of
 Australia based Mayne Group Ltd, to develop and manufacture a range
 of six anti-infective products that Mayne will market and distribute
 in the US and European markets.
 
 -Strides Arcolab enters into an agreement for private placement
 issue
 
 - Strides Arcolab signs License Agreement with KV Pharma for
 exclusive marketing rights in the United States and Canada for 10 new
 generic drugs
 
 -Strides acquires sterile manufacturing facility in Poland
 
 2007
 
 -  Strides Arcolab has got tentative permission from the United
 States Food and Drug Administration (USFDA) for Efavirenz tablets, an
 anti-HIV drug. Efavirenz, is the generic version of Bristol Myers
 Squibb's Sustiva, which helps in preventing the HIV virus from
 reproduction.
 - Strides Arcolab receives 2 more NDA approvals from US-FDA.
 
 2008
 
 - Strides Arcolab Ltd on March 19, 2008 announced its third ANDA
 approval for Fosphenytoin Injection 50mg/mL in 2 ml and 10 ml vials.
 
 2010
 
 - Strides Arcolab Ltd has informed that Mr. V. S. Iyer has been
 appointed as an Executive Director of the Company.
 
 2011
 
 -Strides Arcolab Receives US FDA NOD To Commercialize First Sterlite
 
 
 -Strides announces First European Approval for Oncology Product
 
 -Strides Arcolab receives US FDA Nod to Commercialize First Liquid 
 
 -StridesArcoL Update on acquisition of outstanding minority
 shareholding in Ascent Pharmahealth Limited
 
 -Strides Arcolab joins the Malaysian Bio-xcell Ecosystem
 
 2012
 
 -Strides Arcolab Announces US FDA approval for its 'Brazilian Sterile
 
 
 -Strides Arcolab receives US FDA approval for Methotrexate Injection
 
 -Strides Arcolab Announces Health Canada Approval For Tobramycin
 Injection
 
 -Strides Arcolab acquires Sterile Formulations facility to expand
 core injectable biz
 
 -Strides collaborates with Gilead Sciences
 
Source : Dion Global Solutions Limited
Quick Links for Strides Arcolab
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.